about
Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare FacilitiesTrends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational databasePandemic Influenza (H1N1) and Mycobacterium tuberculosis Co-infection.The incidence and clinical characteristics by gender differences in patients with Kikuchi-Fujimoto diseaseThe impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study.Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsisAn increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock.AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment.Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study.HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS ProjectFalse-positive rate of a "fourth-generation" HIV antigen/antibody combination assay in an area of low HIV prevalence.Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factorsAbnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study.Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient.Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHODLack of effect of dexamethasone on growth of Orientia tsutsugamushi Gilliam in mouse L929 cells.Risk factors for mortality in patients with Serratia marcescens bacteremia.Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea.Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.Clinical usefulness of the 2010 clinical and laboratory standards institute revised breakpoints for cephalosporin use in the treatment of bacteremia caused by Escherichia coli or Klebsiella spp.Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy.A case of bronchiolitis obliterans organizing pneumonia in an HIV-infected Korean patient successfully treated with clarithromycin.Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD.Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD.Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHODEffects of unplanned treatment interruptions on HIV treatment failure - results from TAHODFailure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational databaseCharacteristics of Resting-State Functional Connectivity in HIV-Associated Neurocognitive DisorderMALDI-TOF MS is more accurate than VITEK II ANC card and API Rapid ID 32 A system for the identification of Clostridium species.Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy.Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-PacificClinical factors associated with hepatitis A virus seropositivity in HIV-infected adults living in a country with an epidemiologic shift for hepatitis A virus infection.Incidence of syphilis seroconversion among HIV-infected persons in Asia: results from the TREAT Asia HIV Observational Database.
P50
Q26770759-E80295B8-23DB-444E-A445-88190C94766CQ28542731-37FEDE1A-DA8E-4701-9341-AD38BA48D83BQ30360160-5CCEBF5E-EA9A-4308-9428-8F58ED504B97Q33440168-0D0F9E01-3A52-4E8F-AE90-742CC0627206Q33634460-241456B6-765D-4444-913F-2B4EC04B5062Q33644568-A07589A2-B580-4824-A562-B398745BA4E5Q33734997-0A7671E8-5491-4AA5-A19E-3AF86661027FQ33750051-0963178B-87A5-4E07-B6B6-6A68FDE1E319Q33751148-5CD6E23A-08F3-41AF-8359-D2899C01E791Q33888740-792A14FE-4E2B-40C5-B106-FDA2B65455FAQ33954775-B596CFBE-FDC5-4855-81DD-4E9F66A3D56EQ34076133-A021DB19-F1DD-4EFA-A7D9-937842B5F4AEQ34189925-9A58AF40-896C-4AE5-B997-545EF9E24D0BQ34481581-0D668718-DCDD-4303-8A87-7302775BA53BQ34542179-848034E8-07D4-4278-93F4-52E67EE87694Q34704745-34E367F6-3DD0-4BC7-936D-D6D1C31AD160Q34707766-987C23E4-C1AF-4119-AC80-D30203FB323FQ34838857-9CE86D6D-B52B-40A5-A3AD-E310214AA838Q34989582-BAB1DB0D-89E4-4F7F-94D0-8264B9401995Q35014794-B4EA3653-8768-4532-AA20-332B89102ADCQ35086034-B7D085F9-F952-4B98-A920-5FF2D1D022A6Q35129067-98D83581-2158-4C04-9539-5118F0BD804BQ35140450-70B6EB02-D6F7-4DED-8A05-87F61D6DA4A9Q35156063-6537FA93-2064-4F3F-8519-42D822CFEF58Q35596925-7BF9416C-A465-4770-9DA3-4C5D0E714A42Q35687119-193446F2-6360-45AD-8219-40AEDE24C5E1Q35706053-2E0A6621-9534-4F34-9EDA-80704290E383Q35790371-6F3477C6-169A-4CA0-9C5B-CD0FF215A246Q35810398-64DA47C8-FF96-430C-AEE3-C4D7C8C54A22Q35877689-8D1CFC4B-04F5-4234-965A-731401957815Q35898696-EF082B89-22B0-471A-B1D7-36E2733EA817Q35916153-205E400E-559D-46F6-A2AA-D3453C428BE0Q35948083-78CF0BE5-9FAE-4403-8921-069CB1235F25Q35967212-74BB61BF-846E-4794-8E1C-2DE812B91976Q35996770-7BD6C1E1-A7F8-4F69-91E1-A28BA24E44FBQ36050966-CD558A5A-4D49-4C54-BB3D-CC8C240DEEA1Q36100991-911F8801-077C-4C89-9EAB-4C73CA84B71EQ36113151-40D1C689-AF44-490A-BF07-4A781153195FQ36134665-8A908F2E-8028-411F-8B94-275003026518Q36172801-DB63993D-1220-456A-B81F-246667382316
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jun Yong Choi
@ast
Jun Yong Choi
@en
Jun Yong Choi
@es
Jun Yong Choi
@sl
type
label
Jun Yong Choi
@ast
Jun Yong Choi
@en
Jun Yong Choi
@es
Jun Yong Choi
@sl
prefLabel
Jun Yong Choi
@ast
Jun Yong Choi
@en
Jun Yong Choi
@es
Jun Yong Choi
@sl
P106
P21
P31
P496
0000-0002-2775-3315